Trial Profile
A 6-week, randomized, open-label, comparative study to evaluate the efficacy and safety of rosuvastatin and atorvastatin in the treatment of hypercholesterolaemia in Hispanic subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Apr 2008
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms STARSHIP
- Sponsors AstraZeneca
- 29 Apr 2008 New trial record.